Detalhe da pesquisa
1.
BTK signaling-a crucial link in the pathophysiology of chronic spontaneous urticaria.
J Allergy Clin Immunol
; 153(5): 1229-1240, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38141832
2.
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials.
J Allergy Clin Immunol
; 2024 Feb 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38431226
3.
Urticaria and basophils.
Allergol Int
; 72(3): 369-374, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37221123
4.
The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.
J Allergy Clin Immunol
; 147(6): 2271-2280.e8, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33713769
5.
Current and emerging treatments for chronic spontaneous urticaria.
Ann Allergy Asthma Immunol
; 125(4): 380-387, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31494233
6.
Immunologic Studies of Progesterone-Induced Neutrophilic Urticaria.
Skinmed
; 15(6): 471-472, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29282190
7.
Efficacy and safety of sulfasalazine in patients with chronic idiopathic urticaria.
Ann Allergy Asthma Immunol
; 112(1): 64-70, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24331396
8.
Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.
J Allergy Clin Immunol
; 132(4): 906-11.e1-4, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23791510
9.
Efficacy and Safety of Systemic Corticosteroids for Urticaria: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
J Allergy Clin Immunol Pract
; 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38642709
10.
Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab.
J Allergy Clin Immunol
; 139(5): 1680-1682.e10, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28259446
11.
Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors.
J Allergy Clin Immunol
; 130(5): 1130-1135.e5, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22800400
12.
Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy.
J Allergy Clin Immunol
; 130(5): 1123-1129.e2, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22800401
13.
Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria.
Ann Allergy Asthma Immunol
; 108(1): 20-24, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22192960
14.
Diversity, Disparities, and the Allergy Immunology Pipeline.
J Allergy Clin Immunol Pract
; 10(4): 923-928, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34999273
15.
Existing and Investigational Medications for Refractory Chronic Spontaneous Urticaria: Safety, Adverse Effects, and Monitoring.
J Allergy Clin Immunol Pract
; 10(12): 3099-3116, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36241154
16.
Pharmacokinetic equivalence of CT-P39 and reference omalizumab in healthy individuals: A randomised, double-blind, parallel-group, Phase 1 trial.
Clin Transl Allergy
; 12(11): e12204, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36434739
17.
Regulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumab.
J Allergy Clin Immunol
; 125(4): 902-908.e7, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-20236696
18.
Decreases in human dendritic cell-dependent T(H)2-like responses after acute in vivo IgE neutralization.
J Allergy Clin Immunol
; 125(4): 896-901.e6, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-20132969
19.
Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.
J Allergy Clin Immunol
; 125(4): 889-895.e7, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19962744
20.
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial.
J Asthma Allergy
; 14: 1045-1063, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34429614